Skip to content

Clinical trials

Completed Lipid Metabolism Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Status: Completed Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20141
20161
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kastle Therapeutics, LLC2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Eli Lilly and Company1
Loughborough University1
NewAmsterdam Pharma1
University of Chester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders8
Metabolic Diseases6
Dyslipidemias5
Genetic Diseases, Inborn4
Hypercholesterolemia4
Lipid Metabolism, Inborn Errors4
Hyperlipidemias3
Hyperlipoproteinemia Type II3
Hyperlipoproteinemias3
Infant, Newborn, Diseases3

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.